Company news
PMV Pharmaceuticals, Inc. news in 2024
PMV Pharmaceuticals, Inc.'s news releases, calls and decks from 2024, newest first.
PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 6, 2024
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
October 22, 2024
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
August 7, 2024
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
May 8, 2024
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
March 26, 2024
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
February 28, 2024
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
January 17, 2024
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
January 4, 2024